News
Phase I/II clinical trial studying MG1-HPV in combination with anti-PDL1 antibody in patients with cervical, oropharyngeal and other solid tumors to commence in Q2 2018. May 16, 2018 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results